|
WO2021126973A1
(en)
*
|
2019-12-17 |
2021-06-24 |
Orionis Biosciences, Inc. |
Compounds modulating protein recruitment and/or degradation
|
|
JP2023545274A
(ja)
*
|
2020-10-07 |
2023-10-27 |
クルゲン（シャンハイ），インク． |
癌を処置する化合物および方法
|
|
US20240085421A1
(en)
|
2021-01-13 |
2024-03-14 |
Monte Rosa Therapeutics, Inc. |
Methods for the identification of degrons
|
|
US20240261274A1
(en)
|
2021-01-13 |
2024-08-08 |
Monte Rosa Therapeutics, Inc. |
Treatment of myc-driven cancers with gspt1 degraders
|
|
AU2022207648A1
(en)
|
2021-01-13 |
2023-07-27 |
Monte Rosa Therapeutics Ag |
Isoindolinone compounds
|
|
CN117242060A
(zh)
*
|
2021-01-13 |
2023-12-15 |
蒙特罗萨医疗公司 |
异吲哚啉酮化合物
|
|
WO2022200857A1
(en)
*
|
2021-03-22 |
2022-09-29 |
Monte Rosa Therapeutics Ag |
Pharmaceutical compositions for use in the prevention and treatment of a disease or disorder caused by or associated with one or more premature termination codons
|
|
WO2022256623A1
(en)
|
2021-06-04 |
2022-12-08 |
Monte Rosa Therapeutics, Inc. |
E3 ligase fusion proteins for proximity detection
|
|
CN115504963A
(zh)
*
|
2021-06-22 |
2022-12-23 |
苏州开拓药业股份有限公司 |
一种c-Myc蛋白降解剂
|
|
JP2024527628A
(ja)
*
|
2021-07-19 |
2024-07-25 |
メッドシャイン ディスカバリー インコーポレイテッド |
ヘテロアリール－３－ピペリジンジオン化合物その使用
|
|
WO2023069700A1
(en)
*
|
2021-10-22 |
2023-04-27 |
Monte Rosa Therapeutics, Inc. |
Compounds that mediate protein degradation and methods of use thereof
|
|
WO2023069731A1
(en)
*
|
2021-10-22 |
2023-04-27 |
Monte Rosa Therapeutics, Inc. |
Compounds that mediate protein degradation and methods of use thereof
|
|
WO2023069720A1
(en)
*
|
2021-10-22 |
2023-04-27 |
Monte Rosa Therapeutics, Inc. |
Compounds that mediate protein degradation and methods of use thereof
|
|
WO2023069708A1
(en)
*
|
2021-10-22 |
2023-04-27 |
Monte Rosa Therapeutics, Inc. |
Compounds that mediate protein degradation and uses thereof
|
|
WO2023091567A1
(en)
|
2021-11-17 |
2023-05-25 |
Monte Rosa Therapeutics, Inc. |
Degron and neosubstrate identification
|
|
CA3255290A1
(en)
|
2022-04-14 |
2023-10-19 |
Bristol-Myers Squibb Company |
NEW GSPT1 COMPOUNDS AND METHODS FOR USING THE NEW COMPOUNDS
|
|
WO2024015855A1
(en)
|
2022-07-13 |
2024-01-18 |
Monte Rosa Therapeutics, Inc. |
COMBINATION THERAPY COMPRISING GSPT1-DIRECTED MOLECULAR GLUE DEGRADERS AND PI3K/AKT/mTOR PATHWAY INHIBITORS
|
|
EP4554935A1
(en)
*
|
2022-07-14 |
2025-05-21 |
Monte Rosa Therapeutics AG |
Methods of preparing an isoindolinone derivative and crystal forms thereof
|
|
WO2024027795A1
(zh)
*
|
2022-08-04 |
2024-02-08 |
苏州开拓药业股份有限公司 |
包含Myc蛋白降解剂类生物活性化合物的抗体药物偶联物及其制备方法和用途
|
|
CN115636811A
(zh)
*
|
2022-08-17 |
2023-01-24 |
成都分迪药业有限公司 |
异吲哚啉苄胺衍生物的合成方法
|
|
EP4584259A1
(en)
|
2022-09-09 |
2025-07-16 |
Innovo Therapeutics, Inc. |
Ck1alpha and dual ck1alpha / gspt1 degrading compounds
|
|
KR20260005248A
(ko)
*
|
2023-03-24 |
2026-01-09 |
주식회사 핀테라퓨틱스 |
Gspt1 분해 화합물 및 분해 방법
|
|
CN121311477A
(zh)
*
|
2023-09-06 |
2026-01-09 |
上海超阳药业有限公司 |
内酰胺类衍生物及其应用
|
|
WO2025085416A1
(en)
*
|
2023-10-16 |
2025-04-24 |
Bristol-Myers Squibb Company |
Gspt1 compounds and methods of use of the compounds
|
|
WO2025146112A1
(en)
*
|
2024-01-05 |
2025-07-10 |
Primelink Biotherapeutics (Shenzhen) Co., Ltd. |
Gspt1 degrading compounds and compositions and uses thereof
|
|
WO2025179161A1
(en)
|
2024-02-21 |
2025-08-28 |
Innovo Therapeutics, Inc. |
Protein degrading compounds
|
|
WO2025259615A1
(en)
*
|
2024-06-11 |
2025-12-18 |
Triana Biomedicines, Inc. |
Modulators of cdk2 and uses thereof
|
|
WO2026007898A1
(zh)
*
|
2024-07-01 |
2026-01-08 |
上海海雁医药科技有限公司 |
含苯乙氧基亚烷基胺结构的异吲哚啉化合物、其药物组合物及应用
|